Table 1

Characteristics and outcomes of patients

No.AgeGenderOperationTNMaStagebGradecInvd
169Male4/19/2001T1N0M0III0
270Male1/29/2002T1N1M0IIBI1
355Male11/1/2001T1N0M0II0
466Male11/9/2000T1N0M0III2
576Male11/22/2001T3N0M0IIAII2
658Male3/15/2001T1N1M0IIBII0
775Female4/5/2001T3N1M0IIII1
879Male11/2/2000T3N1M0IIIIII2
982Male11/4/2000T3N1M0IIIIII2
1052Male11/8/2001T1N1M0IIBI2
1159Male5/31/2001T3N1M0IIII2
1256Male12/20/2001T2N1M0IIBII2
  • a T, primary tumor; Tis, carcinoma in situ; T1, invading the lamina propria or submucosa; T2, invading the muscularis propria; T3, invading the adventitia; T4, invading adjacent structures; N0, no regional lymph node metastasis; N1, regional lymph node metastasis; M, metastasis; M0, no metastasis; M1, metastasis.

  • b Stage 0, TisN0M0; stage I, T1N0M0; stage IIA, T2N0M0 or T3N0M0; stage IIB, T1N1M0 or T2N1M0; stage III, T3N1M0 or T4 Any N M0; stage IV, Any T Any N M1.

  • c Grade I, well differentiated; grade II, moderately differentiated; grade III, poorly differentiated.

  • d Inv, lymphovascular invasion; 0, no invasion; 1, mild invasion; 2, more than moderate invasion.